Jasper Therapeutics JSPR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 0.88 | -0.04 | -10,952 | -1 | ||
| 2025Q4 | 1.83 | 174.04 | 0.23 | -15,839 | -9 | |
| 2025Q3 | 2.38 | 102.3 | -1.02 | -19,166 | -19 | |
| 2025Q2 | 5.55 | 101.32 | -1.75 | -27,076 | -27 | |
| 2025Q1 | 4.3 | 102.64 | -1.41 | -21,802 | -21 | |
| 2024Q4 | 21.38 | 103.96 | -1.64 | -25,285 | -24 | |
| 2024Q3 | 18.81 | 106.72 | -1.25 | -19,889 | -19 | |
| 2024Q2 | 22.7 | 109.67 | -0.97 | -15,993 | -15 | |
| 2024Q1 | 29.36 | 109.79 | -1.03 | -15,072 | -14 | |
| 2023Q4 | 7.89 | 106.9 | -1.5 | -17,725 | -17 | |
| 2023Q3 | 7 | 110.36 | -1.6 | -19,362 | -18 | |
| 2023Q2 | 13.7 | 110.86 | -1.46 | -17,827 | -16 | |
| 2023Q1 | 18.1 | 97.81 | -1.62 | -13,947 | -14 | |
| 2022Q4 | 4.83 | 104.06 | -3.63 | -13,747 | -13 | |
| 2022Q3 | 7.89 | 104.61 | -3.2 | -12,708 | -12 | |
| 2022Q2 | 19.3 | 114.98 | -2.9 | -11,963 | -10 | |
| 2022Q1 | 35.5 | 578.98 | -0.6 | -12,778 | -2 | |
| 2021Q4 | 78.5 | 133.34 | 44.4 | -12,082 | -9 | |
| 2021Q3 | 102.6 | 295.75 | 17.6 | -10,079 | -3 | |
| 2021Q2 | 46.89 | -39.7 | 5,478 | 12 |